Drug and Substance Abuse

The Lavenir family filed a wrongful death lawsuit against Airbnb, a rental owner, and the prior renter after their 19-month-old daughter died due to fentanyl exposure.

Two UPS employees are part of a group of five accused of trafficking cocaine in southern Texas. Law enforcement seized approximately 60 kilograms of cocaine.

A panel urged the FDA to give final approval to a plan that would make Narcan, the nasal version of the overdose-reversal drug naloxone, available over the counter.

Walgreens has agreed to pay $83 million to the state of West Virginia to settle a lawsuit claiming the pharmacy chain contributed to the opioid crisis.

Two branches of the Seattle Credit Union are closing in the city due to declining foot traffic and safety concerns. The credit union will close the branches in February.

Oklahoma announced new settlements totaling $226.1 million with three pharmacy chains and a drug manufacturer over the opioid epidemic on Wednesday.

FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.

The first batch of pot crops in New York could potentially be in danger due to a court fight over marijuana dispensary licenses. The fight is expected to hurt small farms.

New Hampshire Attorney General John Formella announced that the state reached a $40.5 million settlement with Johnson & Johnson over opioid claims on Thursday.

West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp.

Allergan and Teva, two popular opioid distributers, have agreed to pay $54 million in cash and overdose reversal drugs to settle a federal lawsuit.

A federal judge ruled on Monday that three major U.S. drug distributors are not responsible for fueling an opioid epidemic in a part of West Virginia.

Walgreens has settled with the state of Florida in a lawsuit concerning the opioid epidemic, in which it has agreed to pay $683 million to help fight against opioid addiction and abuse.

The percentage of working Americans testing positive for drugs hit a two-decade high last year, driven by an increase in positive marijuana tests, as businesses might have loosened screening policies amid nationwide labor shortages.

Families faced the owners of Purdue Pharma in court and told heart-wrenching stories of addiction and death.

Members of the Sackler family who own Purdue Pharma LP and grew wealthy from sales of OxyContin agreed to pay up to $6 billion to settle lawsuits accusing them of helping fuel the opioid-addiction epidemic, earning the unanimous support of state attorneys general to resolve the family’s liability and end the drugmaker’s bankruptcy case.

A U.S. judge on Friday allowed Purdue Pharma to immediately challenge her rejection of legal protections for Sackler family members who own the OxyContin maker, and which were a major component of its bankruptcy reorganization plan.

Regional pharmacy chain operator Giant Eagle Inc on Friday said it had agreed to settle lawsuits accusing it of fueling the opioid epidemic in several Ohio communities,

Rhode Island plans to create supervised spaces for users to inject illegal drugs, in a big test of the idea that reducing harm to drug users is more effective than criminalization.

Objections to a historic settlement with Purdue Pharma are mounting in the form of appeals, with Rhode Island's attorney general saying Wednesday the plan doesn't hold the OxyContin maker or its owners accountable for its role in sparking the opioid crisis.